Unicycive Therapeutics, Inc. (UNCY)
5.34
-0.29
(-5.15%)
USD |
NASDAQ |
Aug 24, 16:00
5.35
+0.01
(+0.19%)
After-Hours: 20:00
Unicycive Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 93.33% |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | 99.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 99.60% |
| Theriva Biologics, Inc. | -- |
| AbbVie, Inc. | 74.71% |
| Decoy Therapeutics, Inc. | 94.02% |
| Nkarta, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.6% |
| Return on Assets | -66.17% |
| Return on Invested Capital | -99.02% |
| Return on Net Operating Assets | -468.1% |